Menu Search
Equities

Abionyx Pharma SA

  • Add to watchlist
  • Add to portfolio
  • Add an alert
0RAG:LSE

Abionyx Pharma SA

Actions
  • Price (EUR)3.42
  • Today's Change0.00 / 0.00%
  • Shares traded142.00
  • 1 Year change+175.36%
  • Beta0.9512
Data delayed at least 20 minutes, as of Feb 16 2026 15:13 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Cash flow in EURView more

In 2024, cash reserves at Abionyx Pharma SA fell by 958.00k. Cash Flow from Financing totalled 2.84m or 62.49% of revenues. In addition the company used 3.63m for operations while cash used for investing totalled 76.00k.
Cash flow per share-0.1281
Price/Cash flow per share--
Book value per share0.1582
Tangible book value per share0.0015
More ▼

Balance sheet in EURView more

Abionyx Pharma SA has a Debt to Total Capital ratio of 42.81%, a higher figure than the previous year's 24.64%.
Current ratio1.40
Quick ratio1.35
Total debt/total equity0.7486
Total debt/total capital0.4281
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.